News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Boston Therapeutics, Inc. Gets First Sales of SUGARDOWN™ in Italy


1/3/2012 7:15:06 AM

MANCHESTER, N.H.--(BUSINESS WIRE)--Boston Therapeutics, Inc., a public company registered with the SEC and a developer of diabetes therapeutics, announced today that it has secured its first purchase order for distribution of SUGARDOWN™ in Italy.

"We are very pleased to announce the first purchase order for SUGARDOWN™ and the introduction of our chewable dietary supplement for glycemic health to the Italian market. With the help of our distributor, SUGARDOWN™ is now listed on Codifa, a national registry for pharmaceuticals in Italy”, said Ken Tassey, President and Chief Operations Officer of Boston Therapeutics.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES